<?xml version="1.0" encoding="UTF-8"?>
<p>Although some benefits could be seen in the use of MQ as antiviral drug, its neurotoxicity should be taken into account: when it is used for malaria prophylaxis, it is known to cause serious neuropsychiatric adverse reactions, and to date, international MQ labels warn patients to discontinue it at the onset of prodromal psychiatric and neurologic symptoms [
 <xref rid="B133-microorganisms-08-00085" ref-type="bibr">133</xref>].
</p>
